arrow
R

Richard S.E. Keefe

Duke University
H指数:96
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploratory anchor-based analyses to determine minimal clinically important differences for the Brief Assessment of Cognition in Schizophrenia and the Schizophrenia Cognition Rating Scale

探索性锚定分析以确定精神分裂症认知简明评估和精神性认知评级量表的最低临床重要差异

2026-07-011
PRE
A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study

鲁瓦达克西STAT在治疗伴有认知障碍的精神分裂症成人中的2期随机对照试验:ERUDITE研究的结果

2026-04-240
OAAI
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials

伊克里匹汀(iclepertin)对精神分裂症相关认知障碍的疗效与安全性(CONNEX项目):三项III期随机对照试验的结果

2025-11-110
PRE
Beyond symptom improvement: transdiagnostic and disorder-specific ways to assess functional and quality of life outcomes across mental disorders in adults

超越症状改善:跨诊断和疾病特异性方法评估成人精神障碍的功能和生活质量结局

2025-09-150
OAAI
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study

评估Schizophrenia Cognition Rating Scale的评分者间信度:一项非干预性定量研究

2025-04-280
OA
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study

根据FAST-MAS研究中获得的与奖励相关的措施,使用潜在特征分析对快感缺乏的受试者进行分类

2023-10-012
OAAI
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders
2023-05-011
OAAI
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers

在精神分裂症和健康志愿者的竞争前,行业主导的研究中验证一套ERP和QEEG生物标志物

2023-04-0112
OAAI